Clinical Trial Results:
A PLACEBO CONTROLLED, RANDOMIZED, PARALLEL COHORT, SAFETY AND TOLERABILITY STUDY OF TWO DOSE LEVELS OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE™) IN PATIENTS WITH BRONCHIECTASIS COMPLICATED BY CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA
Summary
|
|
EudraCT number |
2007-007940-92 |
Trial protocol |
GB BE HU GR BG |
Global completion date |
11 May 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Nov 2019
|
First version publication date |
09 Nov 2019
|
Other versions |
|
Summary report(s) |
TR02-107 CTG Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.